Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Suspended × INDUSTRY × Clear all

Phase

Phase 1 34 Phase 1/2 20 Phase 2 16 Phase NA 8 Phase 3 6 Phase 4 2 Phase 2/3 1

Status

Completed 93 Recruiting 66 Terminated 55 Active not recruiting 29 Not yet recruiting 26 Unknown 24 Withdrawn 13 Enrolling by invitation 3 Suspended 1

Sponsor Class

OTHER 6 NIH 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

lenvatinib 1 Sorafenib 1 Folfox protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05033522 2025-10-23

ALIVE

Mirror Biologics, Inc.

Phase 2/3 Suspended

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡